BioNTech (BNTX) Stock Soars as They Team Up with Pfizer to Develop Coronavirus Vaccine

The German-based biotech firm BioNTech (NASDAQ: BNTX) is soaring after announcing that they are teaming up with American pharmaceutical giant Pfizer (PFE) to develop a coronavirus vaccine.

This will be critical to ending this global pandemic.

But three other firms are also working on a vaccine, including Moderna (MRNA), CureVac (also a German company), and Shanghai Fosun Pharmaceutical.

Click here for more details.